Bhatt, D. L., Szarek, M., Pitt, B., Cannon, C. P., Leiter, L. A., McGuire, D. K., . . . Steg, P. G. (2021). Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. The New England journal of medicine, 384(2), 129-139. https://doi.org/10.1056/NEJMoa2030186
Citace podle Chicago (17th ed.)Bhatt, Deepak L., et al. "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease." The New England Journal of Medicine 384, no. 2 (2021): 129-139. https://doi.org/10.1056/NEJMoa2030186.
Citace podle MLA (9th ed.)Bhatt, Deepak L., et al. "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease." The New England Journal of Medicine, vol. 384, no. 2, 2021, pp. 129-139, https://doi.org/10.1056/NEJMoa2030186.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..